Press ReleasesHelix Expands Pharmacogenomic Test Portfolio to Support Safer Cancer and Alzheimer’s TreatmentsMay 28, 2025
Press ReleasesHelix Launches 23,000-Patient Clinico-Genomic Cohort for Autoimmune Diseases to Advance Drug Discovery and DevelopmentMarch 18, 2025
Press ReleasesHelix Unveils Groundbreaking Real-World Insights at the ACMG Annual Clinical Genetics Meeting, Driving Clinical Care ForwardMarch 13, 2025
VideosPartner Perspectives with Nebraska MedicineGenetic Insights Project helps Nebraskans take charge of their health
1Published ResearchChatbot for the Return of Positive Genetic Screening Results for Hereditary Cancer Syndromes: Prompt Engineering ProjectJune 10, 2025
2Published ResearchIndividuals with PMS2 pathogenic variants are at average risk of cancer before age 60March 19, 2025
3Published ResearchScalable system-wide CYP2C19 pharmacogenomic testing reveals 38% excess incidence of adverse events in metabolizers receiving inappropriate prescriptionsMarch 19, 2025
4Published ResearchPopulation genomic screening leads to improved lipid management in patients with familial hypercholesterolemiaMarch 19, 2025
5Published ResearchUnderestimated risk of secondary complications in pathogenic and glucose-elevating GCK variant carriers with type 2 diabetesNovember 21, 2024
NewsJun 14, 2021How DNA-testing startup Helix became one of the nation's leading coronavirus tracking labsBusiness Insider
Press ReleasesJun 3, 2021Helix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral Surveillance
PodcastsMay 28, 2021The Incrementalist: Genetic Screening for the Whole Population with James Lu MD PhDHealthcareNOW
Press ReleasesMay 6, 2021Marc Stapley Assumes Role of Executive Chairman of the Board of Directors of Helix; President and Co-founder James Lu Appointed President and Chief Executive Officer